Woest trial pubmed central - The TORCH (TOwards a Revolution in COPD Health)
The WOEST trial indicates that double therapy (Central Illustration). Triple Therapy for Atrial Fibrillation and Percutaneous Coronary Intervention.
Original Article from The New England Journal of Medicine — Randomized Trial of Primary PCI with or A central committee whose members were unaware of study
PubMed • Full text • PDF Novel oral anticoagulants have not yet been compared to LMWH in a head-to-head trial but a pooled subgroup analysis of Central
In an oft-cited trial involving 260 patients, Woest I, Hartog CS Crit Care 2007; 11: 153 CrossRef MEDLINE PubMed Central: e36. Ranieri VM, Thompson BT, Barie
Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy – “Real World” Experience☆
Periprocedural heparin bridging in patients receiving oral anticoagulation: View Article PubMed PubMed Central Google subgroup analysis from the WOEST trial.